Suchergebnisse - "Park, Keunchil"

PubPharm (876)

1

Comprehensive analysis of transcription factor-based molecular subtypes and their correlation to clinical outcomes in small-cell lung cancer

enthalten in: EBioMedicine | 2024

von Park, S. | Hong, T. | Hwang, S. | +17

2

Nivolumab Plus Chemotherapy in Epidermal Growth Factor Receptor-Mutated Metastatic Non-Small-Cell Lung Cancer After Disease Progression on Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors : Final Results of CheckMate 722

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Mok, T. | Nakagawa, K. | Park, K. | +20

3

Biomarker-directed targeted therapy plus durvalumab in advanced non-small-cell lung cancer : a phase 2 umbrella trial

enthalten in: Nature medicine | 2024

von Besse, B. | Pons-Tostivint, E. | Park, K. | +35

4

Real-World Efficacy and Safety of Amivantamab for EGFR-Mutant NSCLC

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2024

von Wang, K. | Du, R. | Myall, N. | +24

5

Predicting disease recurrence in limited disease small cell lung cancer using cell-free DNA-based mutation and fragmentome analyses

enthalten in: Translational lung cancer research | 2024

von Park, S. | Kang, J. | Lee, N. | +10

6

Biomarker-driven phase 2 umbrella trial : Clinical efficacy of olaparib monotherapy and combination with ceralasertib (AZD6738) in small cell lung cancer

enthalten in: Cancer | 2024

von Park, S. | Kim, Y. | Min, Y. | +11

7

Brief Report : Comprehensive Clinicogenomic Profiling of Small Cell Transformation From EGFR-Mutant NSCLC Informs Potential Therapeutic Targets

enthalten in: JTO clinical and research reports | 2024

von Zhang, B. | Lewis, W. | Stewart, C. | +33

8

Avelumab Versus Platinum-Based Doublet Chemotherapy as First-Line Treatment for Patients With High-Expression Programmed Death-Ligand 1-Positive Metastatic NSCLC : Primary Analysis From the Phase 3 JAVELIN Lung 100 Trial

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2024

von Reck, M. | Barlesi, F. | Yang, J. | +15

9

Biomarker‐driven phase 2 umbrella trial : Clinical efficacy of olaparib monotherapy and combination with ceralasertib (AZD6738) in small cell lung cancer

enthalten in: Cancer | 2024

von Park, S. | Kim, Y. | Min, Y. | +11

10

Amivantamab plus Chemotherapy in NSCLC with EGFR Exon 20 Insertions

enthalten in: The New England journal of medicine | 2023

von Zhou, C. | Tang, K. | Cho, B. | +126

CommentIn: Cancer Discov. 2023 Dec 12;13(12):OF9. - PMID 37878779

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[88]